These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23069206)

  • 41. Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice.
    Chong AS; Ma L; Yin D; Shen J; Blinder L; XiuLong X; Williams JW; Byrne G; Diamond LE; Logan JS
    Xenotransplantation; 2000 Nov; 7(4):275-83. PubMed ID: 11081762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Unique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.
    Zimmerer JM; Horne PH; Fisher MG; Pham TA; Lunsford KE; Ringwald BA; Avila CL; Bumgardner GL
    Transplantation; 2016 Sep; 100(9):1907-15. PubMed ID: 27379551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM; Ma L; Li Y; Yin D; Shen J; Xu J; Chong AS
    J Immunol; 2009 Feb; 182(3):1314-24. PubMed ID: 19155477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Invariant NKT Cells Promote the Development of Highly Cytotoxic Multipotent CXCR3
    Zimmerer JM; Ringwald BA; Chaudhari SR; Han J; Peterson CM; Warren RT; Hart MM; Abdel-Rasoul M; Bumgardner GL
    J Immunol; 2021 Dec; 207(12):3107-3121. PubMed ID: 34810223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation.
    Ensminger SM; Spriewald BM; Sorensen HV; Witzke O; Flashman EG; Bushell A; Morris PJ; Rose ML; Rahemtulla A; Wood KJ
    J Immunol; 2001 Jul; 167(1):532-41. PubMed ID: 11418692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway.
    Guo Z; Meng L; Kim O; Wang J; Hart J; He G; Alegre ML; Thistlethwaite JR; Pearson TC; Larsen CP; Newell KA
    Transplantation; 2001 May; 71(9):1351-4. PubMed ID: 11403253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft.
    Kwun J; Farris AB; Song H; Mahle WT; Burlingham WJ; Knechtle SJ
    Transplantation; 2015 Dec; 99(12):2485-93. PubMed ID: 26102611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Memory CD4 T Cells Induce Antibody-Mediated Rejection of Renal Allografts.
    Gorbacheva V; Fan R; Fairchild RL; Baldwin WM; Valujskikh A
    J Am Soc Nephrol; 2016 Nov; 27(11):3299-3307. PubMed ID: 27020853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.
    Taylor PA; Lees CJ; Waldmann H; Noelle RJ; Blazar BR
    Blood; 2001 Jul; 98(2):467-74. PubMed ID: 11435318
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
    J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation.
    Zhai Y; Shen XD; Gao F; Coito AJ; Wasowska BA; Salama A; Schmitt I; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
    J Immunol; 2002 Aug; 169(3):1270-6. PubMed ID: 12133948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alloprimed CD8(+) T cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms.
    Zimmerer JM; Pham TA; Wright CL; Tobin KJ; Sanghavi PB; Elzein SM; Sanders VM; Bumgardner GL
    Am J Transplant; 2014 Feb; 14(2):295-304. PubMed ID: 24472191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD4+ and CD8+ T cell priming for contact hypersensitivity occurs independently of CD40-CD154 interactions.
    Gorbachev AV; Heeger PS; Fairchild RL
    J Immunol; 2001 Feb; 166(4):2323-32. PubMed ID: 11160289
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
    J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of peripheral CD154
    Boix F; Legaz I; Minhas A; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Sanchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Minguela A; Muro M
    Clin Exp Immunol; 2021 Feb; 203(2):315-328. PubMed ID: 33025622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
    Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
    Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
    Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
    J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin.
    Metzler B; Gfeller P; Wieczorek G; Katopodis A
    Transpl Immunol; 2008 Nov; 20(1-2):106-12. PubMed ID: 18675355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming.
    Burns AM; Chong AS
    J Immunol; 2011 Jan; 186(1):214-21. PubMed ID: 21135169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arsenic trioxide combined with co-stimulatory molecule blockade prolongs survival of cardiac allografts in alloantigen-primed mice.
    Xu S; Chen J; Wang F; Kang X; Lan T; Wang F; Li Z; Qi Z; Xing J
    Transpl Immunol; 2010 Oct; 24(1):57-63. PubMed ID: 20688163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.